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1 Introduction 
1.1 Aim of the research 
The purpose of my research activity has been to develop cellular and molecular biology 
and isotopic labeling strategies to enable optimization of expression of proteins in 
prokaryotic and eukaryotic cells to characterize them, their interactions and their functional 
processes in their native environment at atomic level. This could be achieved exploiting in-
cell NMR spectroscopy. Protein folding, post translational modifications, such metal ions 
binding or cysteine oxidation, can be studied in the physiological environment in which the 
protein of interest operates; also the effects of environmental aspects such as molecular 
crowding, redox properties, on the properties of the biomolecules and of their functions, 
can be investigated. 
 
1.2 In-cell NMR Spectroscopy 
Atomic resolution methods for the structural characterization of biomolecules are often 
confined to in vitro experimental setups. Macromolecular and, in particular, protein 
knowledge is largely built on studies of isolated proteins in ideal, diluted solutions. These 
conditions are vastly different from the physiological environment in cells, which contain 
complex components and are crowded with macromolecules, their total concentration 
possibly exceeding 300 g L
-1
. X-ray crystallography and high resolution electron 
microscopy are only in vitro approaches due to their requirement for pure samples and 
crystalline or vitrified specimens. Nuclear magnetic resonance (NMR) spectroscopy, the 
only other method for structural investigations at atomic level, allows for the direct 
observation of NMR-active nuclei within any NMR-inactive environment and can thus be 
employed to analyze biomolecules in vivo and inside cells. In-cell NMR spectroscopy 
employs modern methods of isotope labelling and multi-dimensional, isotope-edited 
correlation experiments to obtain structural information on proteins within living cells. 
This approach enables high-resolution snapshots of intracellular protein conformation. 
These structural ‘fingerprints’ may change upon biological interactions, post-translational 
modifications or due to structural rearrangements
1
. 
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Several in-cell NMR applications for structural and functional studies of proteins in 
bacteria have been reported
2-6
. Bacterial in-cell NMR techniques have been successfully 
employed to analyze protein dynamics
7-8
, protein-protein interactions
9
, for de-novo 
resonance assignments
10
 and automated structure determinations in crude cell extracts
11
. 
Also a protein structure determination have been achieved: the structure of the putative 
heavy-metal binding protein TTHA1718 from Thermus thermophilus HB8 overexpressed 
in Escherichia Coli cells was solved
12
. A further application of in-cell NMR spectroscopy 
is the investigation of the tautomerization and protonation state of histidines in the cellular 
environment, since this amino acid is frequently found in the active site of enzymes
13
. 
Why do we wish to extend the applicability of in-cell NMR measurements to eukaryotic 
cells? Prokaryotic organisms exhibit a limited range of biological activities and many of 
the cellular processes that define the prevalent topics in modern biological research are 
absent in bacteria. Post-translational protein modifications serve to regulate biological 
activities in eukaryotes, but are much less common in prokaryotic organisms. The presence 
of organelles and the requirement of regulated cellular transport constitutes another 
characteristic of eukaryotic cell identity. Compartmentalization per se results in the 
creation of sub-cellular environments with different physical and biological properties and 
little is known about the effects that these compartments exert on a protein’s structure or 
function. Moreover, eukaryotic organisms display a high degree of cellular differentiation, 
which leads to functional specification and differences in biological activities in 
neighbouring cell types.  
The first in-cell NMR study of isotopically enriched proteins in higher eukaryotic cells was 
conducted in Xenopus laevis oocytes
14
. Their large size (~1 mm diameter) allows 
microinjection of isotopically labelled proteins, produced in bacteria, into the cytosol. In 
this system, phosphorylation of folded and intrinsically disordered proteins has been 
studied and also structures of nucleic acids has been investigated
15-18
. Alternatively, the 
isotopically labelled proteins could be delivered into the cytoplasm via CPP (cell-
penetrating peptides) linked covalently to the proteins. The proteins are subsequently 
released from CPP by endogenous enzymatic activity or by autonomous reductive 
cleavage. This technique was successfully apply to different proteins, demonstrating the 
broad application of this procedure to studying interactions and protein processing. 
Specifically, the CPP sequence of Tat from HIV-1 was fused to the carboxy terminus of 
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the human ubiquitin and then incubated with human HeLa cells in the presence of 
pyrenebutyrate, which mediates the direct translocation of CPP-linked proteins into the 
cytosol
19
.  
Another method to insert an isotopically labelled protein into the cytosol was developed by 
Ogino et al. They took advantage of the pore-forming toxin streptolysine O to study the 
protein thymosin β4 in human 293F cells20. One attractive feature of this approach, in 
contrast to the CPP strategy, is that no modifications to the protein are required for 
intracellular sample delivery. In-cell NMR spectra are thus uncompromised by CPP tags or 
by additional amino acids that remain present after intracellular tag removal. One 
disadvantage is the requirement for mammalian cells that grow in suspension and for 
highly soluble target proteins. Because the amount of delivered sample depends on passive 
diffusion through the toxin pore, and not on an active uptake process like the CPP case, the 
protein concentration gradient across the cell membrane directly relates to the overall 
transduction efficiency
21
. 
 
Figure 1: The overall different approach for in-cell sample preparation between prokaryotic (a) and 
eukaryotic cells (b). Reprinted from: Selenko, Wagner Looking into live cells with in-cell NMR 
spectroscopy Journal of Structural Biology 158 (2007) 244-253 
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Figure 2: Three methods used up to now to insert proteins into mammalian cells. a) microinjection, b) 
CPP, c) porins. Reprinted from: Ito and Selenko, Cellular structural biology Current opinion in 
Structural Biology 
 
The investigation and characterization of proteins in living cells by NMR spectroscopy has 
to overcame three main difficulties. First, the NMR signals of the molecule of interest must 
be distinguished from the NMR resonances of all other cellular components. This could be 
achieved by overexpressing the macromolecule and labelling with the NMR-active 
isotopes 
15
N and 
13
C; 
19
F labelling has also been employed in some cases. 
15
N-labeling 
creates only a small number of background peaks, whereas full 
13
C-labeling produces 
strong background signals that make the unambiguous identification of resonance of the 
macromolecules of interest difficult. The significantly higher background levels in the case 
of 
13
C-labeling as compared to 
15
N-labeling is due to the higher number of C-H groups in 
the molecules than of N-H groups. Amino acid type selective labelling of proteins can also 
apply for in-cell NMR experiments. Unfortunately, not all amino acids can be used for 
selective labelling procedures; good candidates are those at the end of a biosynthetic 
pathway and do not serve as precursor for other amino acids. Alternatively, in E. Coli, 
specialized auxotrophic strains can be used that have been created for all 20 amino acids. 
Growth media for NMR labelling in E. Coli are simple in their composition, easily 
prepared and, depending on the type of labelling, relatively cheap. Bacteria will also 
incorporate isotopes with high efficiency (~98%). Labelling media for eukaryotic cells are 
sophisticated and expensive. Due to the complexity of most eukaryotic metabolisms, 
isotope incorporation is typically less than 90%. Induction time for recombinant protein 
expression are on the order of days rather than hours, which is likely to increase the 
amount of background labelling artefacts. 
a) b) c) 
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Second, the macromolecule must be able to tumble with a sufficient short correlation time. 
Long rotational correlation times lead to fast relaxation and, therefore, broad peaks. Since 
the rotational correlation time is proportional to the surrounding viscosity, the intracellular 
viscosity is an important parameter for the observation of macromolecules inside living 
cells. The intracellular observation of proteins can, however, become impossible by 
binding of the proteins to other cellular components; this significantly increase the 
rotational time of the protein. In particular, binding to large components, such as 
chaperones and nucleic acids, leads to the disappearance of a protein’s resonances due to 
extensive line broadening. If even larger protein complexes or intracellular aggregates are 
to be investigated by in-cell NMR experiments, solid-state NMR techniques have to be 
employed. 
Third, the cells have to survive inside the NMR tube at least for the time period of the 
experiment. The high cellular density can cause problems through oxygen starvation and 
limiting the amount of available nutrients. If the sensitivity of the selected system (mainly 
the expression level) is high enough, the NMR spectra can be measured relatively quickly 
(less than one hour). Modified NMR tubes that allow for continuous exchange of the media 
can keep cells alive for long times; or bacteria can be kept alive for long periods, 
encapsulated in low-melting agarose. This solution will not only allow the perfusion of the 
bacterial sample, it will also solve the problem of cell sedimentation to the bottom of the 
NMR tube over time. Both problems are more severe with larger and more sensitive 
eukaryotic cells. For them, special bioreactors were designed, but they are based on 10 mm 
NMR tubes, and the larger diameter creates additional problems for high resolution NMR 
spectroscopy, in particular for cryogenic probes
22
. 
Moreover, the biggest disadvantage of NMR spectroscopy is its inherent low sensitivity. In 
particular, for the investigation of the behaviour of biological macromolecules in their 
natural environment, it is important to keep the concentration of the macromolecule of 
interest as close to their natural level as possible. 
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1.3 SOD1 
Cu,Zn superoxide dismutase (SOD1 here after) is a soluble, 32 kDa homodimeric enzyme, 
catalyzing the conversion of superoxide radicals to molecular oxygen and hydrogen 
peroxide, thus providing a defense against oxygen toxicity. SOD1 is one of the three 
human superoxide dismutases present in mammals: copper-zinc superoxide dismutase 
(Cu,ZnSOD1), manganese superoxide dismutase (MnSOD or SOD2), and extracellular 
superoxide dismutase (Cu,ZnSOD3). It was isolated for the first time in 1969 by McCord 
and Fridovich
23
, and it was clear that SOD1 acts as a scavenger of superoxide, through a 
two-step reaction involving reduction and re-oxidation of the copper ion in its active site: 
Cu
2+
 + O2
-
 <−> Cu+ + O2 
Cu
+
 + 2H
+
 + O2
-
 <−> Cu2+ + H2O2 
Primarily, this reaction occurs in the cytoplasm where SOD1 is highly expressed. Indeed, 
SOD1 is localized predominantly in the cytosol, but a portion of it is also found in the 
intermembrane space of mitochondria and in other cellular compartments, including the 
nucleus and the endoplasmic reticulum
24
. 
Structurally, human Cu,Zn SOD1 is a homodimer, with subunits of 154 residues. Each 
subunit is folded in a characteristic eight stranded β-barrel with a Greek key fold. The eight 
β-strands forming the walls of the β-barrel display an overall right handed twist. The first 
sheet is formed by strands 1, 2, 3 and 6 and the second by strands 4, 5, 7 and 8. The loops 
connecting the secondary structure elements can be divided in two groups: the odd loops 
are located on the opposite side of the barrel with respect to regions involved in the 
subunit-subunit interface, while the even loops are in part located at the subunit-subunit 
interface. The two subunits of SOD1 are held together by hydrophobic interactions. The 
contact surface between the subunits comprises the N-terminus, strand  β1, the C-terminus, 
strand β8, the two loop regions: loop IV and loop VI. The extension of the contact region 
explains the high stability of the dimer to thermal and chemical denaturation. 
Each SOD1 monomer contains one Cu and one Zn ion. The Zn ion is tetrahedrally 
coordinated to three histidyl imidazoles (His63, His71, His80) and to an aspartyl 
carboxylate group (Asp83), it is completely buried in the protein and has a structural role
25
. 
The Cu ion is coordinated by four histidines (His46, His48, His63, His120). The two metal 
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ions are bridged by His63. The Cu role in the enzyme is mainly catalytic. The redox 
properties of copper ion permit the disproportionation of superoxide anion to hydrogen 
peroxide and dioxygen.  
 
Figure 3: The solution structure of reduced dimeric Cu,Zn SOD1. Reprinted from: Baci et al., The 
solution structure of reduced dimeric copper zinc superoxide dismutase. The structural effects of 
dimerization. Eur J Biochem 2002, 269:1905-1915 
 
The insertion of copper into Cu,Zn SOD1 requires a copper metallochaperone called CCS 
(copper chaperone for superoxide dismutase)
26-28
. CCS folds into three functionally distinct 
protein domains
29-30
. The N-terminal domain I of CCS has homology to ATX1, another 
copper chaperone. Surprisingly, a CCS molecule lacking this domain can still insert copper 
into superoxide dismutase in vivo
31
. It has been therefore proposed that this ATX1-like 
domain is only needed to maximize CCS function under extreme copper-limiting 
conditions. The central domain of CCS (domain II) is homologous to Cu,Zn SOD1. This 
domain physically interacts with SOD1
32
 and it was suggested to secure the enzyme during 
copper insertion. The C-terminal domain III of CCS is quite small (30 amino acids), yet is 
extremely crucial for activating SOD1 in vivo. This domain is highly conserved among 
CCS molecules from diverse species and includes an invariant CXC motif that can bind 
copper. Domain III is disordered; however, it is predicted to lie in the vicinity of the N-
terminal domain I. Models have been proposed in which domain III, perhaps in concert 
with the N-terminal domain I, directly inserts copper into the active site of SOD1
33
. On the 
contrary, domain II of CCS is proposed to participate in target recognition rather than in 
direct transfer of copper. 
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1.4 ALS-linked SOD1 mutants 
Amyotrophic lateral sclerosis (ALS) is a devastating, fatal neurodegenerative disease that 
specifically targets the motor neurons in the spinal cord and in the brain
34
. It typically has 
an adult onset, starting first with weakness in arms or legs and proceeding relentlessly to 
total paralysis and death. Unfortunately, there is no known cure or effective treatment for 
ALS at present nor the causes of the disease have been identified. Patients generally die of 
respiratory failure within two to five years for first appearance of the diseases symptoms. 
Most instances (90%–95%) of ALS have no apparent genetic link and are termed sporadic 
ALS (sALS). In the remaining 5%–10% of cases there is a family history of the disease, 
and the disease is termed familial ALS (fALS).  
To date, at least 165 different mutations in the sod1 gene have been linked to fALS. The 
majority of these mutations cause single amino acid substitutions at one of at least 64 
different locations but, some cause frameshifts, truncations, deletions, or insertions 
(ALSod, the Amyotrophic Lateral Sclerosis Online Genetic Database, 2012, 
http://alsod.iop.kcl.ac.uk/). Mutations are scattered throughout the sequence of the protein. 
The vast majority of the mutations are genetically dominant. 
 
Figure 4: Mutations of SOD1 observed in patients with fALS. Copper-binding residues are indicated 
by #, zinc-binding residues are indicated by *. ↓ indicates an insertion in the sequence; Δ indicates a 
deletion; ST indicates a stop codon. Highlights: green, positions mutated in patients with FALS; blue, 
mutations introduced in cultured cells; yellow: mutations in transgenic rodents; grey: mutations 
introduced both in cell culture models and transgenic rodents. Reprinted from: Carrì et al., Lessons 
from models of SOD1.linked familial ALS, Trends in Molecular Medicine 
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The toxicity of ALS-SOD1 mutants has been linked to the formation of protein aggregates 
rich in SOD1, observed in tissues from ALS patients, ALS-SOD1 transgenic mice, and in 
cell culture model systems
35
. The precursors of these protein aggregates are thought to be 
soluble oligomeric intermediates in the SOD1 aggregation process. These oligomers are 
believed to be responsible for the toxic gain of function, similar to what occurs in other 
neurodegenerative diseases
36-39
. The mature form of SOD1 is not prone to aggregation, 
whereas the intermediate species of the maturation process (i.e. SOD1 lacking metal ions) 
have been shown to have tendency to oligomerize in vitro
40-42
. The oxidation of the two 
free cysteines of SOD1 (C6 and C111) is responsible of the formation of soluble 
oligomers
43
. Other mechanisms are possible, in which amyloid-like structures form
44-45 
and 
a number of structurally various aggregation products are possible
46-47
. 
Therefore, an impaired maturation process would lead to accumulation of immature SOD1 
species, which are prone to oligomerization. However, most of the studies addressing the 
properties of fALS SOD1 mutants and their effects on the maturation process have been 
performed in vitro, so far from physiological conditions. 
 
1.5 Mia40 
Mia40 is an oxidoreductase, which exerts its biological role in the intermembrane space of 
mitochondria (IMS), where it catalyzes oxidative protein folding. All proteins of the IMS 
are synthesized in the cell cytosol and are then imported into the mitochondria. Most of 
them do not contain any cleavable sequence and are targeted to the mitochondrial IMS 
through unidentified import signals. The IMS import pathway differs from the inner 
membrane or matrix ones, because it does not require ATP or an inner membrane electric 
potential
48
. Proteins, that should reach IMS,  were thought to need to be in an unfolded 
state in the cytoplasm so to be able to enter mitochondria, thanks to their conformational 
flexibility that allows them to go through the translocase of the outer membrane (TOM) 
channel
49
. Once they approach mitochondria and face the IMS, Mia40 interacts with them 
importing them in the IMS and catalyzes the formation of their internal disulfide bonds, 
through the intermediate formation of a mixed disulfide bond between the substrate and its 
catalytic CPC motif
50-53
. Upon interaction with Mia40 and subsequent formation of their 
disulfide bonds, the substrates become folded and are trapped in the IMS
54-55
. Interestingly, 
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Mia40 itself obtains its final structure in the IMS upon the formation of two internal 
disulfide bonds, likely by acting as a substrate of itself
56-57
. Mia40 is then re-oxidized by 
ALR (augmenter of liver regeneration) protein and Mia40 is capable of forming disulfide 
intermediates with newly imported substrates proteins
58
. 
Substrate proteins for Mia40 are IMS proteins, usually less than 20 kDa, containing 
characteristic cysteine motifs, organized in twin CX3C, twin CX9C or CX2C motifs. 
Among them there is the mitochondrial copper chaperone Cox17 (a CX9C substrate), 
which participates in Cu(I) transfer to cytochrome c oxidase (CcO), and the small Tims 
(CX3C substrates), which are chaperones for mitochondrial membrane proteins
59
. Another 
substrate of Mia40 is ALR protein, which does not contain twin “CX3C” or twin “CX9C” 
motifs. Thus, ALR represents an unusual type of substrate of the Mia40-dependent import 
pathway
60
. 
 
Figure 5: Oxidative protein folding mechanism. Reprinted from: Banci et al. PNAS 
 
Thus, Mia40 cycles between two redox states: the oxidized one (Mia403S-S) containing 
three intramolecular disulfide bonds, and the partially reduced form where the disulphide 
bond  in the CPC motif is not formed (Mia402S-S). 
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Structurally, both Mia403S-S and Mia402S-S states have a small helical segment in residues 
56–59 (helix α1) and two longer helical segments (helix α2, residues 65–77, and helix α3, 
residues 88–100), whereas the other 80% of residues, essentially located at the N- and C-
termini, do not take any secondary structural conformation, a large part of them being 
highly flexible. 
The solution structure of the folded central region of Mia402S-S consists of a ‘core’ and a 
‘lid’ on top of it. The core is composed of helices α2 (residues 65–77) and α3 (residues 88–
100), which form an antiparallel α-hairpin kept together by two disulfide pairs, Cys64-
Cys97 and Cys74-Cys87, juxtaposing the CX9Cmotifs. The lid (residues 41–64) folds onto 
the core and is structurally rigid, although it does not have defined secondary-structural 
elements, with the exception of the short helix α1 (residues 56–59). The two residues 
preceding the lid segment, Pro54 and Cys55, also show some α-helical propensity. 
However, the disappearance of the NH signal of Cys55 in Mia402S-S indicates local 
structural flexibility in the CPC region. In contrast, this NH signal is still detectable in 
Mia403S-S, suggesting an increased structural rigidity upon disulfide-bond formation. The 
difference in backbone flexibility between the two redox states of Mia40 may have a role 
in the catalytic process. Notably, the lid contains conserved hydrophobic residues that 
interact with conserved aromatic residues located on one side of the α-hairpin core. Indeed, 
a highly charged region is only present on the α-hairpin face opposite the CPC motif. In 
summary, the salient structural features of Mia40 are: (i) a high proportion of unfolded 
segments at the N- and C-termini,(ii) a folded α-hairpin core stabilized by structural 
disulfide pairings, (iii) a rigid N-terminal lid with an extensive array of hydrophobic 
interactions with one part of the α-hairpin core and (iv) a solvent-exposed CPC motif 
ideally placed to be the active site in the oxidation process. 
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Figure 6: The solution structure of Mia402S-S. Reprinted from: Banci et al., Mia40 ia an oxidoreductase 
that catalyzes oxidative protein folding in mitochondria, Nature structural & molecular biology 
 
1.6 Profilin1 
Profilin1 is a cytoskeletal protein that is found widely throughout eukaryotes and is 
essential in all organisms. This small (15 kDa) globular protein binds three types of 
ligands: actin, phosphoinositides and proteins that contain poly-L-proline
61
. 
It was among the first actin-binding proteins to be characterized; initial studies suggested 
that its main role is to sequester actin monomers in a 1:1 complex and then release actin 
following cell stimulation and an increase in phosphatidylinositol (4,5)-bisphosphate 
[PtdIns(4,5)P2] concentration. Profilin1 promote actin polymerization and it is essential in 
the regulation of cytoskeletal dynamics
62
. 
The poly-L-proline binding site comprises the N-terminal and C-terminal helices of 
profilin1, which form the binding clef for poly-L-proline. It is distinct from the actin-
binding domain, although both seem to overlap with the phosphoinositides binding 
region
63
. 
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Figure 7: The binding sites for actin (red), poly-L-proline (yellow) and phosphoinositides (light grey). 
Reprinted from: Witke, The role of profilin complexes in cell mobility and other cellular processes, 
TRENDS in Cell Biology 
 
Structurally, profilin1 folds into a single compact globular domain. Tracing the profilin1 
chain from N- to C-termini, one finds an α-helix that extends from residues W3 through 
A12 (the two N-terminal residues are disordered). The chain  reverses itself in a loop from 
residues Dl3 to C16 followed by the first two strands of β-sheet: a β-hairpin comprising 
residues Q17-Y24 and S29-V34. These two strands are connected by an irregular loop. The 
chain continues through three short  stretches of helix: a single turn of 3,10-helix spanning 
residues T38-N41; an α-helix spanning residues P44-V51; and an α-helix spanning 
residues F58-N61. The chain then forms a contiguous stretch of five strands of antiparallel 
β-sheet: residues L63-L65, Q68-S76, S84-S91, T97-TI05, and T108-KI15. Finally, the 
chain proceeds to its C-terminus via a long a-helix composed of residues L122-SI37
64
. 
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                                       Figure 8: The structure of Profilin1. Reprinted from: PDB 
 
Mutations in the gene of profilin1 have very recently been shown to be the cause of a 
subgroup of familial amyotrophic lateral sclerosis (ALS). From exome sequencing and a 
large screen of ALS patients, four mutations have been identified. They are C71G, M114T, 
E117G and G118V and lie in proximity to actin-binding site. A synthetic mutant H120E 
profilin1 was utilised as a control, since the mutation is located at a crucial residue for the 
actin binding. From studies in cultured cells, researchers have found that, while the wild-
type profilin1 is present predominantly in the soluble fraction of cells, a considerable 
proportion of the mutants is detected in the insoluble fraction. Furthermore, several higher 
molecular mass species are observed, indicative of cytoplasmatic aggregates
65
.
 
Subsequently, another mutant, T109M , has been identified. T109 is positioned close to the 
actin binding domain and contributes to a cluster together with the other PFN1 ALS 
mutation. This amino acid is highly conserved among vertebrates and is subject to 
phosphorylation. Therefore impaired phosphorylation of profilin1 might contribute to 
motoneuron degeneration
66
. 
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Figure 9: Three dimensional illustration of T109M mutation and the 4 amyotrophic lateral sclerosis 
mutations. Reprinted from Wu et al. (2012). Blue: actin; red: profilin 1. 
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2 Results 
A new approach to apply in-cell NMR to human proteins in human cells, with respect to 
those already used by few other researchers, has been developed: proteins has been directly 
over-expressed in human cells to perform in-cell NMR experiments. Protein expression 
was obtained by DNA transient transfection mediated by polyethylenimine (PEI), a 
cationic polymer that binds DNA and enters inside cells via endocytosis and releases it 
inside the nucleus. To validate our method, proteins with different features were selected, 
and the high expression level was estimated by SDS-PAGE. These proteins were visible in 
the 
1
H NMR spectra above the cellular background, and SOD1, Mia40 and Atox1 could be 
detected on 
1
H-
15
N SOFAST-HMQC spectra on uniformly 
15
N labelled cell samples. 
Glutaredoxin1, Thioredoxin1 and Profilin1 were not detected and only became visible 
upon cell lysis, suggesting that some interactions occur in the cytoplasm which makes the 
proteins tumbling slower on average, thus broadening the amide crosspeaks beyond 
detection. 
However, before this approach becoming generally applicable, a number of technological 
limitations has been to overcome: 1) the short lifetime of human cells in the NMR tube 
requires optimization of experimental conditions to maintain cellular viability and reduce 
data acquisition time, while increasing measurement sensitivity; 2) expression of 
isotopically labelled proteins must occur at high enough levels for their detectability in 
NMR experiments at the currently attainable limits of spectral sensitivity; 3) when 
biochemical processes of interest require the intervention of other proteins, these need to 
be co-expressed. Procedures to address and either overcome or reduce the above 
limitations have been generated and this methodological approach was applied to address 
few functional processes, including protein folding, metal uptake and disulfide bond 
formation. 
One of the characterized systems is SOD1, an enzyme that is involved in the cellular 
defence against oxidative stress, catalyzing the dismutation of the superoxide anion into 
molecular oxygen and hydrogen peroxide. The post-translational modification steps, i.e. 
zinc binding, homodimer formation, copper uptake and formation of the intrasubunit 
disulfide bond between cysteine 57 and 146, which occur in SOD1 after its synthesis, have 
been studied in human HEK293T cells and in E. Coli cells.  
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The hSOD1 gene was transfected in HEK293T cell, and SOD1 was detected by in-cell 
NMR at closer-to-physiological intracellular concentrations (45 ±10 μM). 
In cells grown without supplements of zinc or copper ions and at the highest expression 
level, two forms of SOD1 were detected in similar amounts: the monomeric, metal-free 
species (apo-SOD1) and the dimeric species with one Zn
2+
 ion bound to each subunit 
(E,Zn-SOD1). The observed mixture is due to residual zinc in the culture medium. Cys57 
and Cys146 were reduced in both species. The same behaviour in the redox state was 
found also in E. Coli cells: the protein had all its cysteines in the reduced state.  
Addition of Zn
2+
 to the culture medium eliminated apo-SOD1 species signals, either in 
human cells and E. Coli cells. Therefore, Zn
2+
 ions are efficiently taken up by cells in 
culture and bind specifically to the native binding site of dimeric SOD1 in stoichiometric 
amounts. When reduced apo-SOD1 is exposed to Zn
2+
 ions in vitro or in cell lysates, even 
at sub-stoichiometric concentrations, a mixture of forms is generated that includes apo-
SOD1, E,Zn-SOD1 and Zn,ZnSOD1 (in which a second Zn2+ is bound to the copper 
binding site). Therefore, site-selectivity of Zn
2+
 binding can be achieved only in the 
physiological cellular context. 
Whereas the mechanisms for copper uptake are simple in prokaryotes, they are tightly 
regulated in eukaryotic cells. In E.Coli, 100 μM CuSO4, in addition to ZnSO4, was added 
in the expression medium 15 minutes before the cells collecting. The Cu(I),Zn-SOD1 was 
detected by in-cell NMR and ~50% of the SOD1 intrasubunit disulfide bond is formed. 
Copper entrance in eukaryotic cells and its delivery to copper proteins require a number of 
steps, involving specific chaperones responsible of its intracellular trafficking. Copper 
incorporation of SOD1 in eukaryotes is known to be dependent on the CCS protein.  
When cells were co-transfected with hSOD1 and hCCS genes in zinc supplemented 
medium, SOD1 is in the dimeric zinc-containing species, and the SOD1 intrasubunit 
disulfide bond is partially oxidized (around 50%). Therefore there is a mechanism of CCS-
mediated SOD1 disulfide oxidation which does not rely on the presence of copper. 
When cells were incubated with Cu(II), a higher ratio of Cu(I),Zn-SOD1 vs E,Zn-SOD1 is 
obtained (~1:1) compared with cell samples with basal CCS level, indicating that CCS has 
also a role in promoting copper incorporation in SOD1. Therefore, copper added as Cu(II) 
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salt to the culture medium was reduced to Cu(I) and it was stoichiometrically bound to 
expressed SOD1, forming Cu(I),Zn-SOD1. When the test was repeated at concentration 
near the physiological ones, the complete formation of oxidized Cu(I),Zn-SOD1 was 
observed. 
The redox state of SOD1 cysteines is affected by both overexpression of CCS and presence 
of copper. Indeed, when cells overexpressing both SOD1 and CCS are incubated with 
Cu(II), the intrasubunit disulfide bridge of SOD1 is completely oxidized. 
 
The same maturation steps have been studied also in ALS-linked SOD1 mutants, to 
investigate if they follow the complete sequence of the post-translational modification 
steps or if the mutated proteins acquire a misfold. In absence of added metal ions, all 
mutants were in the apo, partially unfolded state, similar to what was observed for WT 
SOD1. Zinc binding step was investigated: even with excess Zn
2+
, several mutants (A4V, 
I35T, and G85R) did not bind the metal ion, and remained in the apo state. For G37R, 
G93A and I113T SOD1 mutants, only a small intracellular amount of zinc-containing 
protein (E,Zn-SOD1) was detected (~15% of the total protein), while the remaining 
fraction was in the apo state. Conversely, V7E, T54R and V148I SOD1 mutants behaved 
like WT SOD1: they stoichiometrically bound one Zn
2+
 ion per monomer, and only the 
folded, homodimeric E,Zn-SOD1 forms were present.  
The effect of hCCS in the maturation of SOD1 mutants was assessed by inducing 
simultaneous expression of each SOD1 mutant and hCCS in media supplemented with zinc 
and copper, and by analyzing the protein metallation and cysteine redox state. With the 
exception of G85R mutant, the fully mature form (Cu(I),Zn-SOD1
SS
) was detected for 
each mutant, indicating that the SOD1 mutants had reached the mature state when both 
hCCS and copper were available in the cytoplasm in sufficient amount; a fraction of E,Zn-
SOD1
SS
 was also present for some mutants (namely V7E, G37R, T54R, G93A, I113T, 
V148I) as well as for WT SOD1. Notably, for the mutants with impaired intracellular zinc 
binding, the total amount of zinc-containing protein (i.e. the sum of E,Zn-SOD1 and 
Cu(I),Zn-SOD1 species) was higher in these cellular conditions than that measured in zinc-
supplemented cells with only endogenous levels of CCS. The overexpressed CCS 
somehow promoted zinc binding to apo-SOD1 mutants, and then subsequently transferred 
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copper and catalyzed cysteine oxidation, resulting in a higher intracellular amount of 
mature SOD1. To determine whether copper-free CCS alone could promote zinc binding to 
apo-SOD1 mutants, we analyzed cell samples overexpressing [
15
N]Cys-labeled G37R, 
G93A and I113T SOD1 together with CCS, without supplementing extra copper. In these 
conditions a mixture of species was generated, which included apo-SOD1
SH
, E,Zn-
SOD1
SH
, and E,Zn-SOD1
SS
, showing that Cu-free CCS was actually less efficient than Cu-
CCS in increasing the amount of zinc-containing forms for the mutants, and in catalyzing 
the disulfide bond formation. The ability of Cu-CCS to rescue the zinc binding step in the 
maturation of a set of fALS mutants suggests that CCS may in fact act as a molecular 
chaperone for these mutants beyond copper and disulfide transfer. 
 
Another investigated system has been Mia40, that is an oxidoreductase that catalyzes 
oxidative protein folding in the mitochondrial intermembrane space (IMS). The folding 
and redox state, prior to mitochondrial import in live human cells, have been observed. 
Mia40 in the cytoplasm is present in a folded and in a disulfide-oxidized state, while the 
CPC motif is still reduced.  
The dependence of Mia40 redox and folding state on the overexpression of Glutaredoxin1 
(Grx1) and Thioredoxin1 (Trx1), two proteins that are involved in the regulation of protein 
thiol groups in the cellular cytoplasm, was investigated.  
In presence of Grx1, the folded conformation of Mia40 was poorly detected, while the 
crosspeaks of the unfolded parts were still visible in the uniform 
15
N labelled spectrum. 
The amount of folded Mia40 was measured in the cell extract by standard addition of pure 
folded Mia40, using the methyl peak at -0.7 ppm as a marker of the folded state of Mia40. 
Total Mia40 was determined on the same cell extract by Western-Blot, using the same pure 
Mia40 for reference. A ratio of 23±3% folded Mia40 over total Mia40 was obtained. 
The effect of Trx1 on the Mia40 state was also investigated by inducing co-expression of 
Trx1 with Mia40. Trx1 affected the folding state of Mia40 to a lesser extent than Grx1 
when expressed at similar levels because 50% of cytoplasmic Mia40 was still in the folded, 
oxidized state. Therefore, the two thiol-regulating proteins have different efficacy in 
keeping Mia40 reduced, despite being reported to have overall similar functions in the 
cytoplasm. 
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Figure S1: Combined Chemical Shift Difference (CCSD) plot of in-cell vs. in vitro zinc-
bound hSOD1 NMR spectra 
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Figure S2: Cysteine redox state determined by reaction of hSOD1 with AMS 
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Figure S3: Supernatant after centrifugation of the cell sample 
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Supporting Information S1. Reaction with AMS 
 
Reaction with 4-acetamido-4’-maleimidylstilbene-2,2’-disulfonic acid (AMS) was 
performed directly on cell samples in oxygen-free conditions [1]. 1 mL of cell culture was 
precipitated with 10% trichloroacetic acid (TCA), washed with 80 µL acetone and re-
suspended in 100 µL 100 mM Tris pH 7 + 2% SDS. 10 µL of the mixture obtained was 
incubated 1 h at 37°C with 20 mM AMS, and finally run on a non-reducing SDS-PAGE. 
The same reaction was performed on in vitro samples of hSOD1
S-S
 and hSOD1
SH-SH
. 20 µL 
of an in vitro protein sample (0.2 mM) were precipitated with 10% TCA, washed with 40 
µL acetone and re-suspended in 50 µL 100 mM Tris pH 7 + 2% SDS. 10 µL of the mixture 
obtained was incubated 1 h at 37°C with 20 mM AMS. 
 
 
 
References: 
 1.  Kobayashi T, Ito K (1999) Respiratory chain strongly oxidizes the CXXC 
motif of DsbB in the Escherichia coli disulfide bond formation pathway. EMBO J. 18: 
1192-1198. 
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Supporting Information S2. Cell and lysate samples preparation 
 
Cell samples preparation 
The M9 buffer used in all cell cultures was checked through ICP-AES for traces of zinc. 
The concentration of Zn
2+
 was below the detection limit of 0.04 µM. 
Cell samples for in-cell NMR were prepared as follows: a cell culture was grown overnight 
at 30°C in 35 mL of LB medium. After gentle centrifugation (3000 g) for 20 minutes, the 
cells were re-suspended in 50 mL of M9 minimal medium [M9 buffer (7 g/L K2HPO4, 3 
g/L KH2PO4, 0.5 g/L NaCl, pH 7.4), 2 mM MgSO4, 0.1 mM CaCl2, 1 mg/L biotin, 1 mg/L 
thiamine, antibiotic] containing 1 g/L (
15
NH4)2SO4 and 3 g/L of unlabelled glucose to 
obtain an OD600 of ~1.6. After 10 min recovery time, overexpression was induced with 0.5 
mM IPTG, and carried out at 30°C for 4 h. The cells were washed once with 50 mL of 
metal-free M9 buffer in order to remove nutrients, metal ions and any excreted by-product, 
and they were harvested through gentle centrifugation. The pellet was then re-suspended in 
metal-free M9 buffer until 500 µL of a ~50% v./v. cell slurry were obtained. 50 µL of D2O 
were added, and the final volume was put in a 5 mm NMR tube.  
 
Cell lysates preparation 
Cleared cell lysates for in-cell NMR experiments were prepared as follows: after removal 
of the supernatant to be checked by NMR, the cell pellet was re-suspended in an equal 
volume of metal-free M9 buffer. The cells were then lysed by ultrasonication. Then the 
lysate was centrifuged at 18000 g for 20 minutes, the supernatant was collected and its 
volume was brought to 500 µL with M9 buffer. 50 µL of D2O were then added. The final 
dilution of the cytoplasm in M9 buffer is around 1:2. 
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Supporting Information S3. hSOD1 purification protocol 
 
Pure hSOD1 protein was prepared as follows: a cell culture (BL21(DE3) Gold 
(Stratagene), transformed with a pET28a plasmid containing the WT hSOD1 gene) was 
grown overnight at 30°C in 750 mL LB, harvested and re-suspended in 2.25 L 
15
N-labelled 
M9 medium. After 4 h from induction with 0.5 mM IPTG at 30°C the cells were harvested 
and re-suspended in 20 mM Tris, pH 8 buffer for lysis. The cleared lysate was loaded on 
an anion exchange column (DEAE Sepharose Fast Flow resin, GE Healthcare) for a first 
purification of hSOD1 by elution with NaCl gradient. The collected fractions containing 
hSOD1 (checked by SDS-PAGE) were further purified by gel filtration (Superdex75 16/60 
column, GE Healthcare) in 20 mM Tris, 100 mM NaCl, pH 8 buffer. Fractions containing 
pure hSOD1 were collected. ZnSO4 was added to the protein solution to increase hSOD1 
stability, and 1 mM DTT was added in all buffers to prevent protein aggregation through 
disulfide bridges. 
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Supplementary Figure 1. Endogenous SOD1 levels in untransfected HEK293T cells 
were measured by Western Blot analysis. The endogenous amount of SOD1 was 
estimated in untransfected total cell lysates by densitometric analysis of band intensities, in 
comparison with different dilutions of pure SOD1. SOD1 was detected using a rabbit anti-
human SOD1 polyclonal primary antibody (BioVision) diluted 1:100 (2µg/ml) and a goat 
anti-rabbit IgG-peroxidase secondary antibody for detection (Sigma), diluted at 1:80000. 
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Supplementary Figure 2. Overexpression of SOD1 and CCS in human cells. 
Coomassie-stained SDS-PAGE of cell extracts from NMR samples of human cells 
expressing SOD1 (1:2 hSOD1:PEI ratio, lane 1), co-expressing SOD1 and CCS (1:1:2 
hSOD1:hCCS:PEI ratio, lane 2) in Zn(II)-supplemented medium. The expression level was 
reduced by lowering the amount of DNA (1:1:4 hSOD1:hCCS:PEI ratio, lane 3). Cell 
extracts were obtained by freeze/thaw lysis followed by centrifugation. Protein bands and 
reference molecular weights are indicated. Protein concentration was estimated by 
comparing band intensities with serial dilutions of a pure SOD1 sample at known 
concentration, ran in the same gel (see Supplementary Fig. 14a,b). 
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Supplementary Figure 3. Cellular fractionation shows that SOD1 is present mainly in 
the cytoplasm. Coomassie-stained SDS-PAGE of sub-cellular fractions obtained from 
human cells expressing SOD1 using a mitochondria isolation kit for cultured cells (Thermo 
Scientific). The nuclear fraction was obtained by washing once the pellet obtained after 
cell rupture, and resuspending it in PBS buffer. C = cytoplasm; M = mitochondria; N = 
nuclei. Relative dilutions are 1:16 (C), 1:1 (M), 1:10 (N) respectively (see Supplementary 
Fig. 14c,d). SOD1 concentration was estimated via SDS-PAGE by comparing each 
fraction at different dilutions with a  dilution series of pure SOD1. 
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Supplementary Figure 4. SOD1 is present both in the metal-depleted form (apo-
SOD1
SH
) and in the zinc-containing form (E,Zn-SOD1
SH
) in cells without metal 
supplementation of tissue culture media. 
1
H-
15
N SOFAST HMQC spectra were 
acquired: a, on human cells expressing uniformly 
15
N-labelled SOD1; b, on the 
corresponding cell extract. In the in-cell NMR spectrum (a) only the crosspeaks of the 
unfolded region of apo-SOD1
SH
 are detected, (at 8.0-8.5 ppm 
1
H, above the cellular 
background signals) while most of the peaks of the folded region are broadened beyond 
detection. Crosspeaks unambiguously assigned to apo-SOD1
SH
 and E,Zn-SOD1
SH
 are 
labelled with red and blue arrows, respectively. Most of the crosspeaks of apo-SOD1
SH
 are 
detected in the cell extract (b), together with those of E,Zn-SOD1
SH
, while no crosspeaks 
from other species are detected. Crosspeaks unambiguously assigned to apo-SOD1
SH
 are 
labelled with red arrows. 
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Supplementary Figure 5. Spectral crowding is reduced by subtracting the 
background signals arising from the non-selective labelling of cellular components. a, 
1
H-
15
N correlation spectrum of cytoplasmic E,Zn-SOD1
SH
 free of background signals 
obtained by subtracting to the 
1
H-
15
N SOFAST-HMQC spectrum shown in Figure 1c the 
spectrum b, of a cell sample transfected with the empty pHLsec vector, containing only 
signals from cellular components. The two spectra were acquired in the same experimental 
conditions. 
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Supplementary Figure 6. Combined Chemical Shift Difference (CCSD) plot of in-cell 
SOD1 vs. in vitro E,Zn-SOD1 and Zn,Zn-SOD1. CCSD plot of a subset of 
1
H-
15
N 
resonances of SOD1 showing that the cytoplasmic zinc-containing SOD1 species 
corresponds to in vitro E,Zn-SOD1
SH
. CCSDs between cytoplasmic SOD1 and Zn,Zn-
SOD1
SH
 (blue) are higher on average than CCSDs between cytoplasmic SOD1 and E,Zn-
SOD1
SH
 (orange). CCSDs were calculated using the formula: 
   21521 5
2
1
2
1
NHCCSD  
. 
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Supplementary Figure 7. Cu(II) addition to E. coli cells induces formation of 
Cu(I),Zn-SOD1 and partial disulfide oxidation. a, 
1
H-
15
N SOFAST HMQC spectrum of 
E. coli cells expressing uniformly 
15
N-labelled SOD1 incubated with Cu(II); b, 
1
H histidine 
NMR spectrum of E. coli cells expressing SOD1 incubated with Cu(II); c, NMR spectrum 
of E. coli cells expressing SOD1 incubated with Cu(I)-acetonitrile complex; d, 
1
H-
15
N 
SOFAST HMQC spectrum of E. coli cells expressing 
15
N-cysteine labelled SOD1 
incubated with Cu(II). Assigned cysteine residues in d are indicated in red. When two 
species of SOD1 are present, labels indicate the disulfide redox state of each species. 
Unlabelled crosspeaks are cellular background signals.  
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Supplementary Figure 8. The redox state of SOD1 is influenced by copper binding. 
1
H-
15
N SOFAST HMQC spectra were acquired on human cells expressing 
15
N-cysteine 
labelled SOD1 in Zn(II)-supplemented medium, after incubation with Cu(II). Assigned 
cysteine residues are indicated in red. When two species of SOD1 are present, labels 
indicate the disulfide redox state of each species. Unlabelled crosspeaks are cellular 
background signals.  
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Supplementary Figure 9. Histidine region of 
1
H NMR spectra acquired on human 
cells co-expressing SOD1 and CCS. a, cells co-expressing unlabelled SOD1 and CCS; b, 
expressing unlabelled SOD1 (scaled down to match the intensity of SOD1 peaks in a); c, 
expressing unlabelled CCS. Cell samples were transfected in Zn(II)-supplemented 
medium. 
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Supplementary Figure 10. When SOD1 is expressed at lower amounts, CCS catalyzes 
the complete formation of the disulfide bond, and incubation with copper results in 
the complete formation of Cu,Zn-SOD1. 
1
H-
15
N SOFAST HMQC spectra and 
1
H NMR 
spectra were acquired on human cells expressing 45 ± 10 µM SOD1 and 15 ± 3 µM CCS : 
a, 
1
H-
15
N SOFAST HMQC acquired on cells co-expressing 
15
N-cysteine labelled SOD1 
and CCS in Zn(II)-supplemented medium; b, histidine region of 
1
H NMR spectrum 
acquired on the same cells; c, histidine region of 
1
H NMR spectrum acquired on cells co-
expressing 
15
N-cysteine labelled SOD1 and CCS in Zn(II)-supplemented medium, after 
incubation with Cu(II) d, 
1
H-
15
N SOFAST HMQC acquired on the same cells. Assigned 
cysteine residues are indicated in red. In both samples the cysteine crosspeaks of reduced 
SOD1 are not detected (a,d). Histidine protons unambiguously assigned to Cu(I),Zn-SOD1 
species are indicated (b,c). Complete copper incorporation in SOD1 is observed. Protein 
concentration was estimated by comparing band intensities with serial dilutions of a pure 
SOD1 sample at known concentration, ran in the same gel. 
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Supplementary Figure 11. Overexpression of non-hSOD1 protein targets in 
HEK293T cells. a, Coomassie-stained SDS-PAGE of total cell extracts showing the 
overexpression of Mia40 (lane 1), Atox1 (lane 2), glutaredoxin-1 (Grx1, lane 3) and 
thioredoxin (Trx, lane 4), 48 h after transfection (see Supplementary Fig. 14e-g); b, 
aliphatic region of 
1
H NMR spectra of cells expressing Mia40 (red), Atox1 (yellow), Grx1 
(green), Trx (blue) superimposed with cells transfected with empty vector (black).  
1H 
a 
b 
empty 
Mia40 
Atox1 
Grx1 
Trx 
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Supplementary Figure 12. In-cell NMR detection of non-hSOD1 protein targets. a, 
1
H-
15
N SOFAST HMQC spectrum of HEK293T cells expressing U-
15
N labelled Mia40; b, 
1
H-
15
N SOFAST HMQC spectrum of HEK293T cells expressing U-
15
N labelled Atox1; c, 
1
H-
15
N SOFAST HMQC spectrum of HEK293T cells expressing U-
15
N labelled 
glutaredoxin-1; d, 
1
H-
15
N SOFAST HMQC spectrum of HEK293T cells expressing U-
15
N 
labelled thioredoxin. Mia40 (a) and Atox1 (b) are clearly detected above the cellular 
background, while glutaredoxin-1 (c) and thioredoxin (d) are not detected due to slow 
tumbling in the cytoplasm. 
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Supplementary Figure 13. NMR spectra of the cell sample supernatants confirm the 
absence of protein leaked out of the cells. 
1
H-
15
N SOFAST HMQC spectra were 
acquired on the supernatants obtained from each cell sample, after the actual in-cell NMR 
experiments, to check whether protein leakage has occurred.  a, 
1
H projection of the 
1
H-
15
N SOFAST HMQC supernatant spectrum (shown in b) of cells containing U-
15
N E,Zn-
SOD1 (black line) compared to the 
1
H projection of the in-cell NMR spectrum (grey line); 
b, 2D 
1
H-
15
N SOFAST HMQC supernatant spectrum; c, 2D 
1
H-
15
N SOFAST HMQC 
supernatant spectrum of a cell sample containing 
15
N-cysteine labelled SOD1 and CCS. 
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Supplementary Figure 14. Uncut SDS-PAGEs. a, SDS-PAGE of Supplementary Fig. 2 
(lanes 1,2); b, SDS-PAGE of Supplementary Fig. 3 (lane 3); c, SDS-PAGE of 
Supplementary Fig. 3 (lanes C,M); d, SDS-PAGE of Supplementary Fig. 3 (lane N); e, 
SDS-PAGE of Supplementary Fig. 11 (lane 1); f, SDS-PAGE of Supplementary Fig. 11 
(lanes 2,4); g, SDS-PAGE of Supplementary Fig. 11 (lane 3). Cut lanes are indicated with 
arrows. 
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Introduction 
 
An atomic level approach is required to characterize physiological processes and their 
alteration, in order to understand the molecular cause of their malfunction in pathological 
states and to develop treatments and therapeutic protocols. Ideally, these processes should 
be studied in the “natural” environment, i.e. within a live cellular context. For that purpose, 
in-cell NMR represents a promising technique (1, 2). We have recently developed an in-
cell NMR approach aimed at obtaining information on the folding and maturation process 
of proteins directly in live human cells (3, 4). This in-human-cell NMR approach was 
applied to monitor maturation events for human proteins such as Mia40 (4) and superoxide 
dismutase 1 (SOD1) (3). The latter is a stable dimer binding a copper and a zinc ion per 
monomer, and forming an intramolecular disulfide bond. We showed that intracellular 
apoSOD1 selectively binds one zinc ion per monomer, and this step is required for the 
protein to interact with its specific chaperone CCS (5), which then transfers copper to 
SOD1 and catalyzes the disulfide bond formation (6-8).  
SOD1 is strongly implicated in the onset of amyotrophic lateral sclerosis (ALS), an adult-
onset neurodegenerative disease characterized by death of motor neurons in the brain and 
spinal cord. While the majority of ALS cases are sporadic (sALS) with no known etiology, 
the remaining cases are genetic in origin and classified as ‘familial’ (fALS). In 1993, it was 
discovered that about 20 % of fALS cases could be related to mutations in the SOD1 gene 
(9). 165 unique fALS-linked SOD1 mutations have been identified so far, which are 
scattered throughout SOD1 amino acid sequence (ALSod, the Amyotrophic Lateral 
Sclerosis Online Genetic Database, 2012, http://alsod.iop.kcl.ac.uk/). The pathogenic role 
of SOD1 in ALS has been linked to the formation of protein aggregates rich in SOD1, 
observed both in the spinal cords of patients with ALS (10-12) and of transgenic mice 
expressing human forms of the protein (13-16), with accumulation primarily in the late 
stage of the disease. The precursors of these protein aggregates are believed to be soluble 
oligomeric intermediates of the SOD1 aggregation process. These oligomers are thought to 
be responsible for the toxic gain of function, similar to what has been proposed for other 
neurodegenerative diseases (17-20). Generation of soluble oligomers was found to occur 
through oxidation of the two free cysteines of SOD1 (C6 and C111) (21), as well as 
through other possible mechanisms (22), which form amyloid-like structures (23, 24) 
among what is likely a number of structurally various aggregation products (25, 26).    
The mature form of SOD1 is not prone to aggregation, whereas the intermediate species of 
the maturation process (i.e. SOD1 lacking metal ions) have been shown to have tendency 
to oligomerize in vitro (21, 27-29). Therefore, an impaired maturation process would lead 
to accumulation of immature SOD1 species, which are prone to oligomerization. Recent 
studies reported the occurrence of a higher propensity for deficient protein maturation in 
vivo or in cell culture models for some fALS mutants (30, 31). However, most of the 
studies addressing the properties of fALS SOD1 mutants and their effects on the 
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maturation process have been performed in vitro, i.e. far from physiological conditions 
(32-34). 
In this work, the maturation process of a set of fALS mutants was studied through the in-
human-cell NMR approach, already successfully applied to wild-type hSOD1 (3). With 
this technique, proteins are overexpressed and isotopically labeled in cultured human cells, 
and information on the intracellular folding, cysteine oxidation and metallation state of the 
protein, is obtained by observing them directly in living cells by NMR. The maturation 
levels of fALS mutants in different cellular conditions (e.g. different levels of copper 
and/or zinc and co-expression of human CCS) were compared to those of wild-type (WT) 
hSOD1. The CCS-dependent maturation of the same set of fALS mutants was also 
examined through in vitro NMR experiments following the same procedure applied to WT 
hSOD1 (8). These two approaches (in-cell and in vitro NMR) allowed us to monitor each 
step of the fALS mutants maturation process, providing atomic-level information on how 
each mutation affects the ability of intracellular hSOD1 to reach its mature, stable state. 
 
Results  
 
A number of fALS-linked SOD1 mutations distributed over the protein structure was 
investigated  (Figure 1). We selected the mutants A4V, V7E, G37R, T54R, G85R, G93A, 
I113T and V148I, featuring various properties as summarized in Table 1. We also selected 
a mutation (G85R) that destabilizes the zinc-binding site (35), and a SOD1 mutation not 
currently linked to fALS (I35T), but which is reported to promote SOD1 aggregation (23) 
(Table 1). With the exception of G85R, all selected mutations occur far from the metal 
binding sites. 
 
Table 1. Properties of the hSOD1 mutations studied in the present work. 
 
Mutations  
A4V Side chain size variation, this mutation appears to have a uniformly 
aggressive disease course with a mean of survival of 1 year after 
onset. 
V7E Dimer interface and charge variation to negative residue 
I35T Non-fALS mutation located on SOD1 β3 strand, the only one 
devoid of known fALS mutations; mutation from polar 
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hydrophobic amino acid to non-polar hydrophilic amino acid. 
G37R Charge variation to positive residue 
T54R Dimer interface. Residue near the disulfide bond and charge 
variation to positive residue  
G85R Charge variation to positive residue. The mutation is located in the 
proximity of the zinc-binding site. 
G93A G93A mutation occurs in a region of hSOD1 in which hydrogen 
bonding interactions are thought to facilitate the “plug” end of the 
-barrel. 
I113T Dimer interface, change to hydrophilic amino acid 
V148I Dimer interface. 
 
 
Impaired zinc binding causes mutant apo-SOD1 to accumulate in the cytoplasm 
SOD1 mutants were overexpressed in HEK293T cells, transfecting them with the same 
amount of DNA for all the mutants, and the expression level of each mutant was compared 
to that of WT SOD1 in the same conditions. The amounts of soluble mutant proteins in the 
cell extracts ranged from 36  8 M (G85R SOD1) to 162  8 M (T54R SOD1), 
compared to 150 M WT SOD1. For each mutant the total amount of intracellular SOD1 
was the same as that of the soluble SOD1, indicating that no significant formation of 
insoluble aggregates occurred to any of the mutants in these cellular conditions (Figure 
S1). In absence of added metal ions, all mutants appear to be in a predominately unfolded 
apo state, similar to what was observed for WT SOD1 expressed in the same conditions, 
where the in-cell NMR spectra show mainly peaks in the 8.0-8.3 ppm (
1
H) region (Figure 
S2). Zinc binding was investigated by inducing protein expression in cells supplemented 
with ZnSO4.  Even with excess zinc, most of the fALS mutants were observed in 
predominately unfolded apo forms (Figure 2). For A4V, I35T, G85R, no zinc forms were 
observed at all, while for G37R, G93A, and I113T only a small intracellular amount of 
zinc containing protein (E,Zn-SOD1) was observed (Figure S3). We have previously 
described the folded E,Zn form of WT SOD1 when the protein is expressed in the presence 
of zinc (3).  In the current study, a similar behavior was observed only for V7E, T54R and 
V148I SOD1 mutants: they stoichiometrically bound one Zn
2+
 ion per monomer, and only 
the folded, homodimeric E,Zn-SOD1 forms were present (Figure 3). The  absence or low 
amounts of E,Zn-SOD1 observed in fALS-linked mutants suggests a possible detrimental 
effect of these mutations for zinc binding. To more thoroughly characterize the ability for 
these mutants to bind zinc, they were also expressed and purified from E. coli for analysis 
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in vitro (Figure S4). E,Zn forms of the G37R, G93A, and I113T were obtained with only 
minimal amounts of the predominately unfolded apo state observed for G93A and G37R. 
The E,Zn form of A4V was also observed, however this mutant appeared to mostly be in 
the predominately unfolded apo state. No metallated form of G85R was obtained and was 
also predominately unfolded, however some dispersed peaks suggested a more structured 
apo form was also present. In preparation for titration with Zn
2+
 G37R, G93A, I113T, and 
AV4 were demetallated and subsequently reduced to their biologically relevant apo-
reduced forms (apo-SOD1
SH
) to directly observe zinc binding. In each case, signals for 
both the predominately unfolded apo and a more structured apo froms were observed, 
however in different ratios, with I113T appearing to have the highest ratio of the more 
structured apo form (Figure S5).  Subsequent titration with Zn
2+
 revealed that only the 
more structured apo form has the ability to bind zinc, as only chemical shifts associated 
with the more structured form were perturbed upon addition of the metal while the 
chemical shifts associated with the predominately unfolded form remained unchanged 
(Figure S5). G85R was also reduced and subsequently titrated with Zn
2+
, and although was 
initially isolated in the apo form, was also observed to bind zinc (Figure S5).            
Using both in-cell and in vitro NMR techniques we identified a predominately unfolded 
form of SOD1 that is unable to bind zinc. To further analyze this species we conducted 
analytical gel filtration experiments on several in vitro samples of fALS mutants (Figure 
S6). A4V, G37R, G85R, and G93A all appeared to have peaks associated with what has 
previously been identified as soluble oligomers (21, 23). Consistently, all of these mutants 
showed considerably high ratios of the predominately unfolded to folded species both in-
cell and in vitro by NMR, in contrast to T54R, which appeared completely folded by 
NMR, and did not exhibit peaks associated with soluble oligomers in the analytical gel 
filtration experiment.        
 
CCS rescues the impaired zinc-binding step of  SOD1 mutants  
The effect of hCCS in the maturation of SOD1 mutants in living cells was assessed by 
inducing simultaneous expression of each SOD1 mutant with hCCS in either U-
15
N-
labeled or [
15
N]Cys-labeled medium supplemented with zinc and copper, and by analyzing 
the protein metallation and cysteine redox state. With the exception of G85R mutant, the 
fully mature form (Cu(I),Zn-SOD1
SS
) was detected for each mutant (Figures 4, 5), while 
no unmetallated forms were detected (Figure S7), indicating that the SOD1 mutants had 
reached the mature state when both hCCS and copper were available in the cytoplasm in 
sufficient amount; a fraction of E,Zn-SOD1
SS
 was also present for some mutants (namely 
V7E, G37R, T54R, G93A, I113T, V148I) as well as for WT SOD1 (Figure 4). Notably, 
for the mutants where the soluble oligomer was detected, the total amount of zinc-
containing protein (i.e. the sum of E,Zn-SOD1 and Cu(I),Zn-SOD1 species) was higher in 
these cellular conditions than that measured in zinc-supplemented cells with only 
endogenous levels of CCS. Fully mature SOD1 was not observed when mutants were 
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coexpressed with hCCS in the absence of supplemented copper (Figure S8). In these 
conditions a mixture of species was generated, which included apo-SOD1
SH
, E,Zn-
SOD1
SH
, and E,Zn-SOD1
SS
, indicating that copper-free hCCS did fully restore the zinc-
binding  step of SOD1 mutants. Together, these results demonstrate that copper is required 
with the coexpression of hCCS to promote mutant SOD1 maturation and prevent the 
formation of the soluble oligomeric species.   
In the in-cell NMR experiments, SOD1 and hCCS were co-expressed in the presence of 
copper and oxygen, therefore the two steps of CCS-dependent maturation – copper transfer 
and disulfide bond oxidation – could not be separated. In order to examine these steps 
separately, and determine if fALS mutations affect the kinetics of either process, we 
characterized the interaction of Cu(I)-hCCS with WT and mutants forms of E,Zn-hSOD1
SH
 
by in vitro NMR experiments. Incubation of WT and fALS mutants V7E, G37R, T54R, 
G85R, G93A, I113T and V148I with Cu(I)-hCCS anaerobically resulted in the formation 
of the Cu,Zn-disulfide reduced forms of hSOD1, with 100% copper transfer for all the 
fALS mutants, and an apparent rate similar to that of the WT protein (Figure 6). Once 
fully copper loaded, exposure to air produced the fully mature Cu,Zn-hSOD1
SS
 form, with 
rates comparable to that of WT SOD1 (Figure 7). Only the T54R mutant protein resulted 
in a considerably slower oxidation of the C57-C146 disulfide bond, although its oxidation 
was faster when copper was transferred by CCS than when Cu(I)-acetonitrile was used as 
the source of copper ,in the absence of CCS. For mutants where the soluble oligomeric 
state was observed together with E,Zn-hSOD1
SH
 (G37R, G85R, and G93A) signals 
associated with the soluble oligomer were unaffected by titration with Cu(I)hCCS (for 
example G85R, Figure S9).   
 
Discussion 
 
We analyzed the maturation process of a set of fALS-linked SOD1 mutants in their 
physiological environment, by comparing the distribution of species produced by the cells 
in different metal abundance, with respect to that of WT SOD1 in the same conditions, and 
we investigated the role of CCS in promoting mutant SOD1 maturation. Many of the 
SOD1 mutants analyzed here appeared to form soluble oligomers when overexpressed in 
cells with only endogenous levels of hCCS, or when coexpressed with hCCS in the 
absence of copper. Conversely, the soluble oligomers were not observed for the same 
mutants when hCCS was coexpressed with the mutant SOD1 in the presence of copper, 
where, in fact, only mature SOD1 forms were detected.  This demonstrates that the soluble 
oligomeric species do not form when the SOD1 CCS-dependent maturation mechanism is 
intact and can readily convert immature E,Zn-hSOD1 forms to fully mature protein. Under 
the current conditions, the absence of Cu(I)-hCCS results in the accumulation of 
monomeric species, which, particularly for the more unstable fALS mutant proteins, likely 
results in unfolding, as predicted by the proposed three-state folding model of SOD1 (2U 
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 2M  N2).  In this model the properly folded monomer (M) is in equilibrium with an 
unfolded monomeric state (U) in addition to the native dimer (N2) (36, 37).  While the 
properly folded monomer readily binds zinc, the unfolded monomer has a significantly 
reduced affinity for the metal (38-40). ALS mutations destabilize the folded monomer and 
shift the equilibrium to favor the unfolded state (41-43), which has been suggested to be 
the starting material for the potentially toxic oligomeric species (33, 41), observed here for 
the first time in the living cellular environment by NMR.   
Identification of the in-cell soluble oligomers was aided by use of in vitro experiments 
using the same fALS mutants. HSQC spectra for the same mutants using both techniques 
reveal strikingly similar peak patterns, suggesting they are in fact the same species. 
Moreover, both seem to be equally unaffected by the presence of excess zinc: 
supplementation of zinc in the media of cells expressing fALS mutants with only 
endogenous hCCS, in the case of in-cell NMR experiments, did not appear to affect the 
peak signals associated with the soluble oligomers, nor, in the case of the in vitro 
experiments, did direct titration of zinc into fALS mutant samples affect the signals 
associated with the soluble oligomers. Together these observations highly suggest that the 
predominately unfolded states observed in fALS mutant samples by both in-cell and in 
vitro NMR are in fact the same species. Furthermore, based on the results of analytical gel 
filtration on in vitro apo-SOD1 samples, we have concluded that the predominately 
unfolded species is most likely in a soluble oligomeric state.    
In experiments with CCS in vitro, with the exception of T54R, the mutations examined did 
not inhibit the interaction of E,Zn-SOD1
SH
 with Cu(I)CCS, and the observed rates of 
copper transfer and disulfide formation for these mutants were similar to those of the WT 
protein. This behavior suggests that the mutations selected did not significantly alter the 
dimer interface, despite their relative proximity, as the mutants were still able to interact 
with hCCS and proceed with normal CCS-dependent maturation. However, the T54R 
mutation may result in the loss of a potentially important intermolecular hydrogen bond 
and introduces a potentially destabilizing positive charge in the vicinity of the disulfide 
bond, which may explain the reduced rate of disulfide formation (see Figure S10 for a 
detailed analysis).  
As previously mentioned, the G85R mutation is located near and destabilizes the zinc 
binding site. In fact, only unmetallated forms of G85R were observed in the in-cell NMR 
samples and when the mutant protein was expressed in E. coli and purified for in vitro 
experiments.  In the in-cell NMR experiment where the G85R mutant was coexpressed 
with hCCS in the presence of copper, no mature protein was detected. This is in agreement 
with previous in vitro work where we also observed that WT apo-SOD1 is unable to 
interact with hCCS, and that zinc acquisition is required before CCS-dependent maturation 
can occur (8). In the current work, with high enough zinc concentrations in vitro, we were 
able to metallate the apo-reduced form of G85R, and monitor its progression through CCS-
dependent maturation (Figure S9).  
 75 
 
Figures: 
 
 
Figure 1: Location of selected fALS mutations of SOD1 (PDB code: 1L3N) examined, 
copper and zinc are shown as yellow and blue spheres, respectively.  The side chains of 
Cys57 and Cys146 are also shown as yellow sticks. 
 
.         
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Figure 2: A predominately unfolded apo form was observed for some fALS SOD1 
mutants, even with excess zinc in the cell culture. 
1
H-
15
N SOFAST HMQC spectra 
acquired on human cell samples expressing uniformly 
15
N-labeled SOD1 mutants in 
Zn(II)-supplemented medium. 
 77 
 
 
 
Figure 3: Some SOD1 mutants behaved like WT SOD1, and stoichiometrically bound one 
Zn
2+
 ion per monomer, when present in excess in the cell culture. 
1
H-
15
N SOFAST HMQC 
spectra acquired on human cell samples expressing uniformly 
15
N-labeled WT SOD1 and 
mutants in Zn(II)-supplemented medium. 
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Figure 4: In excess of zinc and copper, co-expressed CCS allowed the formation of 
Cu,Zn-SOD1 for all mutants, with the exception of G85R. A small amount of E,Zn-SOD1 
was still present for some mutants. 
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Figure 5: Co-expression of CCS in presence of both zinc and copper catalyzed the 
formation of the mutant SOD1 intramolecular disulfide bond. 
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Figure 6: % E,Zn hSOD1 form before (0) and 36, 72, and 108 minutes after addition of 
Cu(I)hCCS.  Conversion of E,Zn-to-Cu,Zn form was followed by monitoring the amide 
signals for residues G73, N139, N140, D124, and L126, as they are a located in proximity 
to the catalytic metal-binding site. Bewteen 3-5 of these residues were used for each 
experiment. The intenisty of the peaks assocaited with the E,Zn-hSOD1 form for were 
used to determine percent of the E,Zn form, and then averaged.  Error bars indicat one 
standard deviation from the mean.   (Data for G85R mutant not included, see Figure S9). 
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Figure 7: % Cu,Zn-hSOD1
 
reduced form before (0) and 36, and 90 minutes after exposure 
to air for 10 minutes. Copper forms were generated by addition of Cu(I)hCCS or 
Cu(I)acetonitrile, Cu(I)ACN, as labeled.  Conversion of the reduced to the oxidized form 
of the protein was followed by monitoring the amide signals for G141, G61, and C146; 
G141 and G61 are located near the disulfide bond formed between C57 and C146.  The 
percent of the reduced form of the protein was determined by the ratio of the intensity of 
the peaks associated with the reduced and oxidized form, for each of the 3 residues, and 
averaged. Error bars indicate one standard deviation from the mean.   (Data for G85R 
mutant not included, see Figure S9). 
 
 
 
 
 
 
 
 82 
 
 
Supplementary Materials  
 
 
Figure S1: Amount of overexpressed SOD1 mutants in whole cells (dark gray) and in cell 
extracts (light gray) from cells grown in zinc-supplemented medium, relative to WT SOD1 
overexpressed in the same conditions.  
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Figure S2: In absence of added metal ions, SOD1 mutants were mostly in the apo state, 
which is partially unfolded, similar to WT SOD1. 
 
 84 
 
 
 
 
 
Figure S3: Projections over the 15N dimension of the in-cell NMR spectra of figure 2, 
showing that small amounts of E,Zn-SOD1 species are detected in cells expressing G37R, 
G93A and I113T SOD1 mutants. The in-cell NMR spectrum of WT E,Zn-SOD1 (scaled at 
0.125x) is shown in gray as reference. 
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Figure S4: HSQC spectra of WT SOD1 and fALS mutants after purification indicate that 
in each case the E,Zn-hSOD1
SS
 form was isolated, with the exception of G85R, where the 
apo-oxidized form was isolated. 
WT#
I113T#
G93A#
G37R#
A4V# G85R#
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Figure S5: HSQC spectra of fALS mutants after demetallation and reduction (left side) 
and titrated with Zn
2+
 (right side). 
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Figure S6: Analytical size exclusion gel filtration of fALS apo reduced mutants: T54R 
(blue), G93A (red), G37R (pink),G85R (green), A4V (grey).  
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Figure S7: In presence of zinc and copper, co-expression of CCS allowed the formation of 
the mature form of SOD1 mutants (Cu,Zn-SOD1
SS
), and no apo-form was detected. 
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Figure S8: Cu-free CCS was less efficient than Cu-loaded CCS in increasing the amount 
of Zn-containing mutant SOD1 and in catalyzing disulfide bond formation, and a mixture 
of species was generated. 
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Figure S9: Overlay of HSQC spectra of E,Zn-G85R
SH
 (black) after addition of Cu(I)hCCS 
(red) and exposure to air (blue). Selected regions highlight the amide signal of residue Gly-
73, which is demonstrative of copper binding because it is located in proximity to the 
catalytic metal-binding site, and the chemical shifts of side chain signals of Asn-53, which 
are affected by both copper binding and oxidation. Asn-53 is located in loop 4 of hSOD1 
and faces the C57-C146 disulfide on its formation. Due to the low intensity of the folded 
G85R signals, in comparison to those associated with the soluble oligomer, we were 
unable to analyze the spectra of the G85R titration with Cu(I)CCS in the same fashion as  
the other mutants.     
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Figure  S10: Crystal structure interfaces of (A) yCCS (cyan) and ySOD (grey) (PDB: 
1JK9), (B) dimeric apoT54R
SS
 (PDB: 3ECW), and (C) dimeric apoT54R
SS
 (grey) 
superimposed with domain 2 of hCCS (cyan) (PDB:  1DO5)   
The slower rate of oxidation observed for T54R SOD1 may be the result of the loss of a 
potential intermolecular hydrogen bond between T54 of hSOD1 and R104 of hCCS,  as 
observed in the yeast proteins (a) (44). This hydrogen bond may stabilize the region 
around C57 of hSOD1 optimizing it for the disulfide bond transfer from the CXC motif of 
domain 3 of hCCS to hSOD1.  In the crystal structure of dimeric T54R apo-hSOD1
SS
, R54 
from one subunit forms a novel hydrogen bond with N19 from the other subunit (b) (45).  
Superimposition of the structure of domain 2 of hCCS (46) over one monomer of T54R 
apo-hSOD1
SS
 brings R104 of hCCS in proximity of R54 of the other hSOD1 monomer, 
suggesting that the T-to-R mutation, in addition to eliminating the potential hydrogen 
bond, further destabilizes the region due to the proximity of the positively charged arginine 
side chains (c). 
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Visualization of the protein fold and redox state in living cells as a 
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Supplementary Figures: 
 
 
 
 
Figure S1, related to Figure 1: Overexpressed Mia40, Grx1 and Trx1 are mostly 
localized in the cytoplasm; Grx1 and Trx1 are fully reduced. (A) Cytoplasmic and 
mitochondrial fractions of cells were blotted at increasing dilutions to assess the 
intracellular distribution of overexpressed Mia40, Grx1 and Trx1. Dilutions are expressed 
relative to the most concentrated mitochondrial extract. The subcellular fractions were 
obtained using a mitochondria isolation kit for cultured cells (Thermo Scientific). The 
fraction purity was checked with a mitochondrial and a cytoplasmic marker (COX IV and 
GAPDH, respectively). (B) Endogenous levels and subcellular localization of Grx1 and 
Trx1 were measured by dot blot analysis of cytoplasmic and mitochondrial extracts. Pure 
samples at known concentration were blotted as a reference. (C) AMS thiol alkylation 
reaction on a cell extract containing overexpressed Grx1 was detected by Western Blot, 
showing that all Grx1 cysteines are reduced. Purified Grx1 was run as a reference. The 
same reaction was performed on a cell extract containing Trx1 overexpressed in presence 
of fully active TrxR, showing that all Trx1 cysteines are reduced. 
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Figure S2, related to Figure 2: Oxidized, folded Mia40 is reduced in vitro upon heat 
denaturation in reducing conditions. 
1
H-
15
N SOFAST HMQC spectra were acquired on 
pure U-
15
N Mia40
2S-S
 (A) before and (C) after denaturation at 95°C in presence of 10 mM 
GSH. After denaturation, the crosspeaks of the N- and C-terminal unfolded segments of 
Mia40 are still visible (with sharper lines), while those corresponding to the core segment 
of oxidized Mia40 disappear. AMS reaction was performed on Mia40 samples before and 
after denaturation, which were run on Coomassie-stained SDS-PAGE (B, D), confirming 
the reduction of the two structural disulfide bonds.  
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Figure S3, related to Figure 3: The amide signals of cytoplasmic Grx1 and Trx1 are 
broadened beyond detection. 
1
H-
15
N SOFAST-HMQC spectra were acquired on samples 
of human cells expressing (A) Grx1 and (C) Trx1, and on the corresponding cell extracts 
(B, D). Only the cellular background signals were visible in the spectra of intact cells, 
where the amide crosspeaks of Grx1 and Trx1 are broadened beyond detection. Upon cell 
lysis, the crosspeaks of both proteins were detected. 
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Figure S4, related to Figure 3: Mass spectrometry analysis shows absence of 
glutathionylated Mia40. MALDI TOF/TOF analysis of Mia40 isolated from cell extracts 
(native Mia40) and Mia40 in vitro samples (GSFT-Mia40). (A) Extract of cells 
overexpressing Mia40 alone; (B) extract of cells co-expressing Mia40 and Grx1; (C) in 
vitro Mia40 heat denatured in 20 mM GSH (phosphate buffer, pH 7), after removal of 
GSH; (D) same sample as (C), incubated with 2 eq. of Grx1 in 20 mM GSH, after removal 
of GSH. Points in the spectra corresponding to increasingly glutathionylated forms of 
Mia40 are indicated (+305.3 Da for each GSH molecule). 
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2.5   Profilin1 results: 
The synthetic gene encoded for profilin1 protein was purchased from eurofins company. It 
was cloned in the pHLsec vector between the restriction enzymes Eco RI and XhoI. 
1
H-
15
N 
SOFAST-HMQC spectra on uniformly 
15
N labelled cells over-expressing profilin1 were 
acquired. Protein signals were not detected and only became visible upon cell lysis, 
suggesting that some interactions occur in the cytoplasm which makes the proteins 
tumbling slower on average, thus broadening the amide crosspeaks beyond detection. The 
same behaviour was observed for the mutant H120E. The other ALS mutants (C71G, 
M114T and G118V) did not reach an enough protein expression level in the soluble 
fraction and none NMR spectra were acquired. 
Since this protein interacts with phosphoinositides inside cells, the residues in this binding 
domain should be mutated in order to minimize this interactions and to try to make it 
visible by in-cell NMR experiments. Mutations (K70N, R89A, K91E, R136A and R137D) 
were introduced in the gene of the wild-type protein and test expression was positive for all 
constructs. 
The wild-type and the mutated gene was cloned in some pET vectors in order to express 
them in E. Coli cells, to purify the proteins and to study their behaviour in vitro. pET 
vectors were chosen to obtain or the native or the histidine tagged proteins to facilitate the 
purification. For all the constructs the exploited restriction enzymes were NdeI and XhoI. 
The purified sample was produced as follow: a massive culture of the histidine tagged 
protein was grown in minimal medium M9 at 37°C for 8h (for WT and H120E) or at 25°C 
O/N (for M114T and G118V). The cleared lysate was loaded in a nickel-chelating HisTrap 
column for an affinity chromatography. After digestion with Factor Xa protease O/N at 
25°C, the protein was separated from the affinity tag in a HisTrap column. The purity of 
the sample was checked with SDS-PAGE. 
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3 Methodological Aspects 
3.1 Cell lines 
Human cells, adherent HEK (Human Embryonic Kidney) 293T cells, were maintained in 
DMEM medium supplemented with l-glutamine, antibiotics (penicillin/streptomycin) and 
10% foetal bovine serum (FBS) and were incubated at 310 K, 5% CO2 in a humidified 
atmosphere. HEK293T cells have some advantages like to be easy-handling, have robust 
growth rate, excellent transfectability, high capacity for recombinant protein expression 
and low-cost media requirements. They are available from all major cell banks and support 
repeated passages (twice a week for at least four months) without losing the above 
properties.  
 
Figure 10: HEK293T cells. Reprinted from ATCC web site 
 
3.2 Gene cloning 
The genes of all proteins were cloned in the pHLsec plasmid between the restriction 
enzymes Eco RI and XhoI. The pHLsec plasmid contains a secretion signal sequence for 
the expressed protein secretion in the medium. The choice of these two particular 
restriction enzymes allows the elimination of this signal sequence and thus the 
cytoplasmatic protein expression. Mutated proteins were obtained by site-directed 
mutagenesis. All the DNA clones were confirmed by DNA sequencing. 
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DNA was purified using the Endotoxin-Free Plasmid Maxi Kit (Macherey-Nagel). High-
quality DNA is essential for successful transfection and only samples with an OD260/OD280 
ratio of 1.8 or higher are suitable. The DNA samples must be sterile; therefore, care should 
be taken to wash the DNA precipitates properly with 70% ethanol before dissolving them 
in sterile water. 
 
Figure 11: pHLsec vector 
 
 
3.3 DNA transient transfection in human cells 
DNA transient transfection differentiate itself from stable transfection because the DNA 
does not integrate into the host genome. A number of delivery reagents are available. 
Polyethylenimine (PEI) is a very affordable and highly efficient transfection reagent and 
there is now a significant number of publications reporting its use (Kichler, 2004; 
Demeneix & Behr, 2005). A large selection of PEI forms are available, varying in 
molecular weight and branching. The employed PEI is ‘25 kDa branched’, which was 
found to be most effective in transfecting various cells lines (Durocheret al.2002). Stock 
solutions are made in water, first at 100 mg ml
-1
(PEI is an extremely viscous liquid). Once 
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the solution is homogeneous, it is further diluted to 1 mg ml
-1
, the pH adjusted to 7, filter 
sterilized and aliquoted. PEI is a polycationic reagent that binds the negatively charged 
DNA and promotes the binding of the complex to anionic proteoglycans that are present on 
the cell surface. Through endocytosis, the PEI/DNA complex enters into the cells, reach 
the nucleus where the DNA is released. 
Optimal transfection is achieved when adherent cells reach about 90% confluency. For a 
standard 75 cm
2
 flask, 25 µg of plasmid DNA are required. The DNA is added to 2,5 mL 
of serum-free medium and is followed by the addition of 50 µg of PEI in serum-free 
medium and gently mixed. The solution is incubated for 20 min at room temperature to 
allow DNA/PEI complex formation. During complex formation, media from the flask to be 
transfected should be changed, lowering the serum concentration to 2%. Finally, the 
DNA/PEI complex is added to the flask, which is then briefly rotated to allow mixing and 
the cells are placed in the incubator. For co-expression of two proteins, the optimal DNA 
ratio between the two construct was chosen.  
 
3.4 Protein expression 
During protein expression, cells are incubated at 310 K in 75 cm
2
 flasks. DMEM medium 
is used for unlabelled in-cell NMR samples; BioExpress6000 medium (CIL) is used for 
uniform 
15
N labelling; for selective 
15
N-cysteine labelling, a reconstituted medium is 
prepared following the DMEM reported composition, in which 
15
N-cysteine is added 
together with all the other unlabelled components.  
When metals are needed, Zn(II) is supplemented as ZnSO4, which is added to the 
expression medium to a final concentration of 10 µM immediately after transfection. 
Cu(II) is supplemented as CuCl2, added to a final concentration of 100 µM after 48 hours 
of protein expression, and incubated for 24 hours. To ensure complete activation of Trx1, 
sodium selenite is supplemented to the cell culture medium to a final concentration of 100 
nM, starting 24 hr before transfection. 
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3.5 NMR sample preparation 
Samples for in-cell NMR were prepared following a reported protocol with some 
variations: HEK293T cells from a 75 cm
2
 culture flask were detached with trypsin-EDTA 
0,05% and resuspended in 20 mL DMEM containing 10% FBS to inactivate trypsin. Cells 
were gently centrifuged (800 g), resuspended in 10 mL PBS, washed once with PBS and 
resuspended in one cell pellet volume of DMEM medium supplemented with 90 mM 
glucose, 16 mM HEPES buffer, 10% D2O. The cell suspension was transferred to a 3 mm 
Shigemi NMR tube; the glass plunger was not used. 
Cleared cell lysates for in-cell NMR experiments were prepared as follows: after the 
experiments, cells were resuspended in the supernatant, removed from the NMR tube and 
spun down again to collect the medium for the protein-leakage test. Cells were lysed by the 
freeze-thaw method after being suspended in one pellet volume of PBS buffer 
supplemented with 0.5 mM EDTA and 4-(2-aminoethyl)-benzenesulfonyl fluoride 
hydrochloride (AEBSF). The lysate was centrifuged at 16,000 × g for 60 min at 4 °C, and 
the cleared cell extract was collected for NMR and SDS-PAGE analysis. 
 
3.6 NMR experiments 
NMR experiments on human HEK293T cells were acquired using a 950-MHz Bruker 
Avance III spectrometer equipped with a CP TCI CryoProbe. 1D 
1
H and 2D 
1
H-
15
N 
SOFAST HMQC spectra were acquired at 305 K. The total acquisition time for each cell 
sample ranged from 1 to 2 h. 
NMR spectra on E. Coli cell samples were acquired at 305 K using an 800-MHz Bruker 
Biospin spectrometer equipped with a TXI CryoProbe. The total acquisition time for each 
cell sample ranged from 1 to 4 h. 
 1D 1H 
The aliphatic region of 
1
H NMR spectra (-1 to 1 p.p.m.) were used to check the protein 
over-expression over the cellular background, obtained with cells transfected with empty 
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vector. This spectrum region is free from cellular background signals, hence the methyl 
groups of the proteins are easily detectable. 
For the study of the metallation state of hSOD1 protein, a 1D 
1
H NMR spectrum with a 
larger spectral window (0-16 p.p.m.) was utilised to allow the detection of histidines 
signals, since their resonance frequencies are shifted at higher p.p.m., due to the metal 
binding. 
 2D 1H-15N SOFAST-HMQC 
Fast data acquisition in SOFAST-HMQC is realized by using very short inter-scan delays. 
SOFAST-HMQC combines the advantages of a small number of radio-frequency pulses, 
Ernst-angle excitation, and longitudinal relaxation optimization to obtain an increased 
signal to noise ratio for high repetition rates of the experiment. 
The main features of SOFAST-HMQC are the following: (i) the HMQC-type H–X transfer 
steps require only few radio-frequency pulses which limits signal loss due to B1-field 
inhomogeneities and pulse imperfections. A reduced number of radio-frequency pulses 
become important if the experiment is performed on a cryogenic probe, where B1-field 
inhomogeneities are more pronounced. (ii) The band-selective 
1
H pulses reduce the 
effective spin-lattice relaxation times (T1) of the observed 
1
H spins. The presence of a 
large number of non-perturbed 
1
H spins, interacting with the observed 
1
H via dipolar 
interactions (NOE effect), significantly reduces longitudinal relaxation times and the 
equilibrium spin polarization is more quickly restored. (iii) The adjustable flip angle of the 
1
H excitation pulse allows further enhancement of the available steady-state magnetization 
for a given recycle delay The performance of SOFAST-HMQC critically depends on the 
choice of the pulse shapes for the band-selective excitation and refocusing pulses on the 
1
H 
channel. [Schanda and Brutscher, SOFAST-HMQC experiments for recording two-
dimensional heteronuclear correlation spectra of proteins within a few seconds, Journal of 
Biomolecular NMR (2005) 33: 199–211] 
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3.7 Assessment of cell viability 
The viability of the cells before and after each in-cell NMR experiment is checked by 
trypan blue staining. Live cells with intact cell membranes are not coloured by the dye. 
Since cells are very selective in the compounds that pass through the membrane, in a viable 
cell trypan blue is not absorbed; however, it traverses the membrane in a dead cell. Hence, 
dead cells are shown as a distinctive blue colour. The number of stained cells was counted 
under phase-contrast microscope and the cell viability always remained above 90%. 
 
3.8 Western Blotting 
Western blot is an analytical technique used to detect and analyse specific proteins in a 
given sample of cells or cellular extract. The sample is subjected to gel electrophoresis for 
protein separation and the proteins are then immobilized on a nitrocellulose membrane 
following electrophoretic transfer from the gel. Non-protein binding areas on the 
membrane are blocked to prevent non-specific binding of antibodies. The membrane is 
incubated with a primary antibody that specifically binds to the protein of interest. 
Unbound antibodies are removed by washing and a secondary antibody conjugated to an 
enzyme, a fluorophore or an isotope is used for detection. The detected signal from the 
protein:antibody:antibody complex is proportional to the amount of protein on the 
membrane. The most commonly used method for detection is chemiluminescence, based 
on secondary antibodies conjugated with horseradish peroxidase enzyme. On the addition 
of a peroxide-based reagent, the enzyme catalyses the oxidation of luminol resulting in the 
emission of light. The light signal can be captured either using a charge-coupled device 
(CCD) camera-based imager or by exposure to X-ray film. Quantitative protein analysis 
was achieved by densitometry using ImageJ program. 
 
3.9 E. Coli samples preparation 
Cell samples for in-cell NMR were prepared as follows. For uniform 
15
N labelling, 
BL21(DE3) Gold E. Coli strain was used, transformed with a pET28a plasmid containing 
the WT hSOD1 gene sequence without any additional tag. For selective 
15
N-cysteine 
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labelling, the auxotroph strain BL21(DE3) CysE was transformed with a pET21 plasmid 
containing the same WT hSOD1 gene sequence. A cell culture was grown overnight at 
30°C in 35 mL of LB medium. After gentle centrifugation (3000 g) for 20 minutes, the 
cells were re-suspended in 50 mL of M9 minimal medium [M9 buffer (7 g/L K2HPO4, 3 
g/L KH2PO4, 0.5 g/L NaCl, pH 7.4), 2 mM MgSO4, 0.1 mM CaCl2, 1 mg/L biotin, 1 mg/L 
thiamine, antibiotic] containing 1 g/L (
15
NH4)2SO4 and 3 g/L of unlabelled glucose to 
obtain an OD600 of ~1.6. For expression of selective 
15
N-cysteine labelled WT hSOD1 the 
samples were prepared as described above, but a M9-based reconstituted medium was 
used, containing 
15
N-cysteine and the other 19 unlabelled amino acids. After 10 min 
recovery time, over-expression was induced with 0.5 mM IPTG, and carried out at 30°C 
for 4 h. The cells were washed once with 50 mL of metal-free M9 buffer in order to 
remove nutrients, metal ions and any excreted by-product, and they were harvested through 
gentle centrifugation. The pellet was then re-suspended in metal-free M9 buffer until 500 
µL of a ~50% v./v. cell slurry were obtained. 50 µL of D2O were added, and the final 
volume was put in a 5 mm NMR tube.  
Cleared cell lysates for in-cell NMR experiments were prepared as follows: after removal 
of the supernatant to be checked by NMR, the cell pellet was re-suspended in an equal 
volume of metal-free M9 buffer. The cells were then lysed by ultrasonication. Then the 
lysate was centrifuged at 16000 x g for 20 minutes, the supernatant was collected and its 
volume was brought to 500 µL with M9 buffer. 50 µL of D2O were then added. The final 
dilution of the cytoplasm in M9 buffer is around 1:2. 
 
3.10 Protein purification 
 hSOD1 
Pure hSOD1 protein was prepared as follows: a cell culture (BL21(DE3) Gold 
(Stratagene), transformed with a pET28a plasmid containing the WT hSOD1 gene) 
was grown overnight at 30°C in 750 mL LB, harvested and re-suspended in 2.25 L 
15
N-labelled M9 medium. After 4 h from induction with 0.5 mM IPTG at 30°C the 
cells were harvested and re-suspended in 20 mM Tris, pH 8 buffer for lysis. The 
cleared lysate was loaded on an anion exchange column (DEAE Sepharose Fast Flow 
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resin, GE Healthcare) for a first purification of hSOD1 by elution with NaCl gradient. 
The collected fractions containing hSOD1 (checked by SDS-PAGE) were further 
purified by gel filtration (Superdex75 16/60 column, GE Healthcare) in 20 mM Tris, 
100 mM NaCl, pH 8 buffer. Fractions containing pure hSOD1 were collected. ZnSO4 
was added to the protein solution to increase hSOD1 stability, and 1 mM DTT was 
added in all buffers to prevent protein aggregation through disulfide bridges. The 
removal of the metals to obtain E,E-hSOD1
S-S
 was achieved by dialyzing several times 
a diluted solution of hSOD1 against 10 mM EDTA in 50 mM acetic acid at pH 3.5. 
After removal of EDTA E,Zn-hSOD1
S-S 
and Zn,Zn-hSOD1
S-S 
were then obtained by 
adding at pH 5.5 one and two equivalents of ZnSO4, respectively. To obtain E,E-
hSOD1
SH-SH 
and E,Zn-hSOD1
SH-SH
, the E,E-hSOD1
S-S 
and E,Zn-hSOD1
S-S 
were 
incubated 1 h at 37°C with 50–60 mM of DTT; 1 mM EDTA was added to the sample 
of E,E-hSOD1
SH-SH 
to prevent binding of any metal present in traces. DTT 
concentration was then brought to 2 mM by dialysis against oxygen-free phosphate 
buffer. Zn,Zn-hSOD1
SH-SH 
was obtained by adding ZnSO4 in excess (4 equivalents) to 
a sample of reduced E,E-hSOD1
SH-SH
. The final NMR samples obtained were in 20 
mM phosphate buffer at pH 7.5. 
 
 hMia40 
Pure hMia40 protein was prepared as follows: a cell culture of BL21(DE3) Gold 
(Stratagene) transformed with a pDEST-His-MBP (Addgene) plasmid containing the 
hMia40 gene, was grown overnight at 30°C in 15 mL LB, harvested and re-suspended 
in 1.5 L of 
15
N-labelled M9 medium. Protein expression was induced with 0.7 mM 
IPTG for 16h at 25°C. Cells were harvested and re-suspended in 20 mM Tris, 500 mM 
NaCl, 5 mM Imidazole, pH 8 buffer for the lysis by ultrasonication. The cleared lysate 
was then processed for the purification. It was performed using a HiTrap chelating HP 
column (Amersham Pharmacia Biosciences) charged with Ni(II). The protein was 
eluted with the 20 mM Tris, 500 mM NaCl, 300 mM Imidazole, pH 8, buffer. His-
MBP tag was cleaved with AcTEV protease (Invitrogen) O/N at 25°C, and separated 
from the N-terminal His-MBP domain with a second purification step. A gel filtration 
using a HiLoad 26/60 Superdex 75 (Amersham Pharmacia Bioscience) column was 
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further required to obtain a high  purity (>95%) protein sample. The sample buffer was 
then exchanged with 50 mM potassium phosphate, 0.5 mM EDTA, 1 mM DTT, pH=7 
to perform NMR experiments. 
 
 hGlutaredoxin1 
hGlutaredoxin1 for in vitro interaction with hMia40 was produced as follows: a 
pTH34 vector containing the human Grx1 gene (N-term fused with His-tag and TEV 
recognition site) was transformed in E. coli BL21(DE3) Gold competent cells. A cell 
culture was grown overnight at 30°C in 10 mL LB, harvested and re-suspended in 1L 
of minimal medium M9. When O.D.600 reached 0.6, protein expression was induced 
with 0.5 mM IPTG for 16 h at 25 °C. hGlutaredoxin1 was purified by affinity 
chromatography using a nickel chelating HisTrap (GE Healthcare) column. The 
fractions containing pure hGrx1 (checked by SDS-PAGE) were digested with AcTEV 
protease (Invitrogen) O/N at 25 °C. The protein was separated from the affinity tag in 
a HisTrap column. The sample buffer was then exchanged with 50 mM potassium 
phosphate, 0.5 mM EDTA, pH=7 to perform NMR experiments. 
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4 Conclusions 
 
In conclusion, in this research project, cellular and biological strategies were developed in 
order to optimize protein expression in prokaryotic and eukaryotic cells. Functional 
processes, such as protein folding, metal-uptake and cysteine oxidation, were investigated 
through in-cell NMR spectroscopy, that is a technique that allows the characterization of  
biological molecules, their interactions and their functional processes in their native 
environment at atomic level. To obtain human proteins over-expression in human cells, a 
new approach with respect to those already used by few other researchers, was developed. 
Procedures to address and either overcome or reduce the observed technological 
limitations were created. In particular, the functional processes involving the maturation 
steps of SOD1 protein and of ALS-linked SOD1 mutants and the folding of Mia40 prior 
the import in the inter-membrane space of mitochondria, also when Glutaredoxin1 and 
Thioredoxin1 were co-expressed, were studied. 
In-cell NMR spectroscopy has demonstrated to be a useful and suitable technique to study 
functional processes involving proteins in their physiological environment and should be 
applied to other proteins implicated in human diseases. 
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